{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28821760", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2019", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "08", "Day": "18"}], "Language": ["eng"], "ELocationID": ["8706", "10.1038/s41598-017-08948-1"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "7", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Aug", "Day": "18"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "A database of breast oncogenic specific siRNAs.", "Pagination": {"StartPage": "8706", "MedlinePgn": "8706"}, "Abstract": {"AbstractText": ["Breast cancer is a serious problem causing the death of women across the world. At present, one of the major challenges is to design drugs to target breast cancer specific gene(s). RNA interference (RNAi) is an important technique for targeted gene silencing that may lead to promising novel therapeutic strategies for breast cancer. Therefore, identification of such molecules having high oncogene specificity is the need of the hour. Here, we have developed a database named as Breast Oncogenic Specific siRNAs (BOSS, http://bioinformatics.cimap.res.in/sharma/boss/ ) on the basis of the current research status on siRNA-mediated repression of oncogenes in different breast cancer cell lines. BOSS is a resource of experimentally validated breast oncogenic siRNAs, collected from research articles and patents published yet. The present database contains information on 865 breast oncogenic siRNA entries. Each entry provides comprehensive information of an siRNA that includes its name, sequence, target gene, type of cells, and inhibition value, etc. Additionally, some useful tools like siRNAMAP and BOSS BLAST were also developed and linked with the database. siRNAMAP can be used for the selection of best siRNA against a target gene while BOSS BLAST tool helps to locate the siRNA sequences in deferent oncogenes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Near Kukrail Picnic Spot, Lucknow, 226 015, Uttar Pradesh, India. ks26atul@gmail.com."}], "LastName": "Tyagi", "ForeName": "Atul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ICT Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Near Kukrail Picnic Spot, Lucknow, 226 015, Uttar Pradesh, India. m.semwal@cimap.res.in."}], "LastName": "Semwal", "ForeName": "Manoj", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Near Kukrail Picnic Spot, Lucknow, 226 015, Uttar Pradesh, India. ashoksharma@cimap.res.in."}], "LastName": "Sharma", "ForeName": "Ashok", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "RNA, Small Interfering"}], "MeshHeadingList": [{"QualifierName": ["genetics"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Databases, Genetic"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Internet"}, {"QualifierName": [], "DescriptorName": "Oncogenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "RNA, Small Interfering"}, {"QualifierName": [], "DescriptorName": "Suppression, Genetic"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Jemal A, et al. Global cancer statistics. CA. Cancer J. Clin. 2011;61:69\u201390. doi: 10.3322/caac.20107.", "ArticleIdList": ["10.3322/caac.20107", "21296855"]}, {"Citation": "Sledge GW, Miller KD. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur. J. Cancer Oxf. Engl. 1990. 2003;39:1668\u20131675.", "ArticleIdList": ["12888360"]}, {"Citation": "Croce CM. Oncogenes and Cancer. N. Engl. J. Med. 2008;358:502\u2013511. doi: 10.1056/NEJMra072367.", "ArticleIdList": ["10.1056/NEJMra072367", "18234754"]}, {"Citation": "Osborne C, Wilson P, Tripathy D. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. The Oncologist. 2004;9:361\u2013377. doi: 10.1634/theoncologist.9-4-361.", "ArticleIdList": ["10.1634/theoncologist.9-4-361", "15266090"]}, {"Citation": "Timmons L, Fire A. Specific interference by ingested dsRNA. Nature. 1998;395:854\u2013854. doi: 10.1038/27579.", "ArticleIdList": ["10.1038/27579", "9804418"]}, {"Citation": "Zheng Y, et al. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles. Theranostics. 2013;3:477\u2013486. doi: 10.7150/thno.6617.", "ArticleIdList": ["10.7150/thno.6617", "PMC3706691", "23843895"]}, {"Citation": "Elbashir SM, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494\u2013498. doi: 10.1038/35078107.", "ArticleIdList": ["10.1038/35078107", "11373684"]}, {"Citation": "Dash R, Moharana SS, Reddy AS, Sastry GM, Sastry GN. DSTHO: database of siRNAs targeted at human oncogenes: a statistical analysis. Int. J. Biol. Macromol. 2006;38:65\u201369. doi: 10.1016/j.ijbiomac.2005.12.024.", "ArticleIdList": ["10.1016/j.ijbiomac.2005.12.024", "16448692"]}, {"Citation": "Ren Y, et al. siRecords: a database of mammalian RNAi experiments and efficacies. Nucleic Acids Res. 2009;37:D146\u2013149. doi: 10.1093/nar/gkn817.", "ArticleIdList": ["10.1093/nar/gkn817", "PMC2686443", "18996894"]}, {"Citation": "Chalk AM, Warfinge RE, Georgii-Hemming P, Sonnhammer ELL. siRNAdb: a database of siRNA sequences. Nucleic Acids Res. 2005;33:D131\u2013134. doi: 10.1093/nar/gki136.", "ArticleIdList": ["10.1093/nar/gki136", "PMC540090", "15608162"]}, {"Citation": "Truss M, et al. HuSiDa\u2013the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells. Nucleic Acids Res. 2005;33:D108\u2013111. doi: 10.1093/nar/gki131.", "ArticleIdList": ["10.1093/nar/gki131", "PMC540085", "15608157"]}, {"Citation": "pubmeddev. Home - PubMed - NCBI. Available at: https://www.ncbi.nlm.nih.gov/pubmed. (Accessed: 21st February 2017)."}, {"Citation": "The Lens. Available at: https://www.lens.org/lens/. (Accessed: 21st February 2017)."}, {"Citation": "Dressing GE, Alyea R, Pang Y, Thomas P. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm. Cancer. 2012;3:101\u2013112. doi: 10.1007/s12672-012-0106-x.", "ArticleIdList": ["10.1007/s12672-012-0106-x", "22350867"]}, {"Citation": "Sun L, et al. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin. Acta Biochim. Biophys. Sin. 2007;39:999\u20131007. doi: 10.1111/j.1745-7270.2007.00361.x.", "ArticleIdList": ["10.1111/j.1745-7270.2007.00361.x", "18064393"]}, {"Citation": "Abdelrahim M, Smith R, Safe S. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol. Pharmacol. 2003;63:1373\u20131381. doi: 10.1124/mol.63.6.1373.", "ArticleIdList": ["10.1124/mol.63.6.1373", "12761348"]}, {"Citation": "Qiao H, et al. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro. Acta Pharmacol. Sin. 2015;36:1085\u20131098. doi: 10.1038/aps.2015.42.", "ArticleIdList": ["10.1038/aps.2015.42", "PMC4561967", "26235741"]}, {"Citation": "Qin B, Cheng K. Silencing of the IKK\u03b5 gene by siRNA inhibits invasiveness and growth of breast cancer cells. Breast Cancer Res. BCR. 2010;12 doi: 10.1186/bcr2644.", "ArticleIdList": ["10.1186/bcr2644", "PMC3096963", "20863366"]}, {"Citation": "Liang Y, et al. siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PloS One. 2010;5 doi: 10.1371/journal.pone.0012860.", "ArticleIdList": ["10.1371/journal.pone.0012860", "PMC2942895", "20877462"]}, {"Citation": "Li J, et al. Role for ezrin in breast cancer cell chemotaxis to CCL5. Oncol. Rep. 2010;24:965\u2013971.", "ArticleIdList": ["20811677"]}, {"Citation": "Pill\u00e9 J-Y, et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol. Ther. J. Am. Soc. Gene Ther. 2005;11:267\u2013274. doi: 10.1016/j.ymthe.2004.08.029.", "ArticleIdList": ["10.1016/j.ymthe.2004.08.029", "15668138"]}, {"Citation": "Glondu-Lassis M, et al. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase. Cancer Res. 2010;70:5116\u20135126. doi: 10.1158/0008-5472.CAN-09-4368.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-4368", "PMC3132424", "20501847"]}, {"Citation": "Howlin J, Rosenkvist J, Andersson T. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res. BCR. 2008;10 doi: 10.1186/bcr2087.", "ArticleIdList": ["10.1186/bcr2087", "PMC2397538", "18435854"]}, {"Citation": "Groth-Pedersen L, et al. Identification of cytoskeleton-associated proteins essential for lysosomal stability and survival of human cancer cells. PloS One. 2012;7 doi: 10.1371/journal.pone.0045381.", "ArticleIdList": ["10.1371/journal.pone.0045381", "PMC3469574", "23071517"]}, {"Citation": "Luo X-G, Zou J-N, Wang S-Z, Zhang T-C, Xi T. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells. IUBMB Life. 2010;62:194\u2013199. doi: 10.1002/iub.288.", "ArticleIdList": ["10.1002/iub.288", "20039369"]}, {"Citation": "Nucleotide BLAST: Search nucleotide databases using a nucleotide query. Available at: https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch (Accessed: 21st February 2017)."}, {"Citation": "Dar SA, Thakur A, Qureshi A, Kumar M. siRNAmod: A database of experimentally validated chemically modified siRNAs. Sci. Rep. 2016;6 doi: 10.1038/srep20031.", "ArticleIdList": ["10.1038/srep20031", "PMC4730238", "26818131"]}, {"Citation": "Tyagi A, et al. HIVsirDB: a database of HIV inhibiting siRNAs. PloS One. 2011;6 doi: 10.1371/journal.pone.0025917.", "ArticleIdList": ["10.1371/journal.pone.0025917", "PMC3191155", "22022467"]}, {"Citation": "Gong W, et al. Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics. 2006;7 doi: 10.1186/1471-2105-7-516.", "ArticleIdList": ["10.1186/1471-2105-7-516", "PMC1698580", "17129386"]}, {"Citation": "Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods San Diego Calif. 2002;26:199\u2013213. doi: 10.1016/S1046-2023(02)00023-3.", "ArticleIdList": ["10.1016/S1046-2023(02)00023-3", "12054897"]}, {"Citation": "Kumar R, Conklin DS, Mittal V. High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 2003;13:2333\u20132340. doi: 10.1101/gr.1575003.", "ArticleIdList": ["10.1101/gr.1575003", "PMC403718", "14525931"]}, {"Citation": "Thakur N, Qureshi A, Kumar M. VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA. Nucleic Acids Res. 2012;40:D230\u2013236. doi: 10.1093/nar/gkr1147.", "ArticleIdList": ["10.1093/nar/gkr1147", "PMC3245049", "22139916"]}]}], "History": [{"Year": "2016", "Month": "12", "Day": "8"}, {"Year": "2017", "Month": "7", "Day": "20"}, {"Year": "2017", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["28821760", "PMC5562753", "10.1038/s41598-017-08948-1", "10.1038/s41598-017-08948-1"]}}]}